Related Experiment Videos
Implementation of the Prostate Cancer Prevention Trial (PCPT)
Phyllis J Goodman1, Catherine M Tangen, John J Crowley
1Southwest Oncology Group Statistical Center, M/S M3-C102, 1100 Fairview Avenue North, Box 19024, Seattle, WA 98109-1024, USA. pgoodman@fhcrc.org
Controlled Clinical Trials
|March 17, 2004
Abstract:
The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.